465 related articles for article (PubMed ID: 11494134)
1. Regulation of Cbl phosphorylation by the Abl tyrosine kinase and the Nck SH2/SH3 adaptor.
Miyoshi-Akiyama T; Aleman LM; Smith JM; Adler CE; Mayer BJ
Oncogene; 2001 Jul; 20(30):4058-69. PubMed ID: 11494134
[TBL] [Abstract][Full Text] [Related]
2. Requirement of multiple SH3 domains of Nck for ligand binding.
Wunderlich L; Gohér A; Faragó A; Downward J; Buday L
Cell Signal; 1999 Apr; 11(4):253-62. PubMed ID: 10372803
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine phosphorylation of p120cbl in BCR/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinase.
Jain SK; Langdon WY; Varticovski L
Oncogene; 1997 May; 14(18):2217-28. PubMed ID: 9174058
[TBL] [Abstract][Full Text] [Related]
4. Activation of the Abl tyrosine kinase in vivo by Src homology 3 domains from the Src homology 2/Src homology 3 adaptor Nck.
Smith JM; Katz S; Mayer BJ
J Biol Chem; 1999 Sep; 274(39):27956-62. PubMed ID: 10488144
[TBL] [Abstract][Full Text] [Related]
5. The kinase-deficient Src acts as a suppressor of the Abl kinase for Cbl phosphorylation.
Shishido T; Akagi T; Ouchi T; Georgescu MM; Langdon WY; Hanafusa H
Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6439-44. PubMed ID: 10829062
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Cbl-Nck and Nck-Pak1 interactions in myeloid FcgammaRII signaling.
Izadi KD; Erdreich-Epstein A; Liu Y; Durden DL
Exp Cell Res; 1998 Dec; 245(2):330-42. PubMed ID: 9851874
[TBL] [Abstract][Full Text] [Related]
7. Yeast two-hybrid in vivo association of the Src kinase Lyn with the proto-oncogene product Cbl but not with the p85 subunit of PI 3-kinase.
Dombrosky-Ferlan PM; Corey SJ
Oncogene; 1997 May; 14(17):2019-24. PubMed ID: 9160881
[TBL] [Abstract][Full Text] [Related]
8. Abl family kinases and Cbl cooperate with the Nck adaptor to modulate Xenopus development.
Adler CE; Miyoshi-Akiyama T; Aleman LM; Tanaka M; Smith JM; Mayer BJ
J Biol Chem; 2000 Nov; 275(46):36472-8. PubMed ID: 10967110
[TBL] [Abstract][Full Text] [Related]
9. Differential inhibition of signaling pathways by dominant-negative SH2/SH3 adapter proteins.
Tanaka M; Gupta R; Mayer BJ
Mol Cell Biol; 1995 Dec; 15(12):6829-37. PubMed ID: 8524249
[TBL] [Abstract][Full Text] [Related]
10. The two major sites of cbl tyrosine phosphorylation in abl-transformed cells select the crkL SH2 domain.
Andoniou CE; Thien CB; Langdon WY
Oncogene; 1996 May; 12(9):1981-9. PubMed ID: 8649859
[TBL] [Abstract][Full Text] [Related]
11. Fyn associates with Cbl and phosphorylates tyrosine 731 in Cbl, a binding site for phosphatidylinositol 3-kinase.
Hunter S; Burton EA; Wu SC; Anderson SM
J Biol Chem; 1999 Jan; 274(4):2097-106. PubMed ID: 9890970
[TBL] [Abstract][Full Text] [Related]
12. The signal transduction through Grb2/Ash in hematopoietic cells.
Odai H; Hanazono Y; Sasaki K; Iwamatu A; Yazaki Y; Hirai H
Leukemia; 1997 Apr; 11 Suppl 3():405-7. PubMed ID: 9209406
[TBL] [Abstract][Full Text] [Related]
13. Interactions of Cbl with two adapter proteins, Grb2 and Crk, upon T cell activation.
Buday L; Khwaja A; Sipeki S; Faragó A; Downward J
J Biol Chem; 1996 Mar; 271(11):6159-63. PubMed ID: 8626404
[TBL] [Abstract][Full Text] [Related]
14. Purification and molecular cloning of SH2- and SH3-containing inositol polyphosphate-5-phosphatase, which is involved in the signaling pathway of granulocyte-macrophage colony-stimulating factor, erythropoietin, and Bcr-Abl.
Odai H; Sasaki K; Iwamatsu A; Nakamoto T; Ueno H; Yamagata T; Mitani K; Yazaki Y; Hirai H
Blood; 1997 Apr; 89(8):2745-56. PubMed ID: 9108392
[TBL] [Abstract][Full Text] [Related]
15. The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway.
Sattler M; Salgia R; Okuda K; Uemura N; Durstin MA; Pisick E; Xu G; Li JL; Prasad KV; Griffin JD
Oncogene; 1996 Feb; 12(4):839-46. PubMed ID: 8632906
[TBL] [Abstract][Full Text] [Related]
16. The product of the cbl oncogene forms stable complexes in vivo with endogenous Crk in a tyrosine phosphorylation-dependent manner.
Ribon V; Hubbell S; Herrera R; Saltiel AR
Mol Cell Biol; 1996 Jan; 16(1):45-52. PubMed ID: 8524328
[TBL] [Abstract][Full Text] [Related]
17. Coexistence of phosphotyrosine-dependent and -independent interactions between Cbl and Bcr-Abl.
Gaston I; Johnson KJ; Oda T; Bhat A; Reis M; Langdon W; Shen L; Deininger MW; Druker BJ
Exp Hematol; 2004 Jan; 32(1):113-21. PubMed ID: 14725908
[TBL] [Abstract][Full Text] [Related]
18. The protein product of the c-cbl oncogene rapidly complexes with the EGF receptor and is tyrosine phosphorylated following EGF stimulation.
Bowtell DD; Langdon WY
Oncogene; 1995 Oct; 11(8):1561-7. PubMed ID: 7478580
[TBL] [Abstract][Full Text] [Related]
19. Association of Nck with tyrosine-phosphorylated SLP-76 in activated T lymphocytes.
Wunderlich L; Faragó A; Downward J; Buday L
Eur J Immunol; 1999 Apr; 29(4):1068-75. PubMed ID: 10229072
[TBL] [Abstract][Full Text] [Related]
20. The proto-oncogene product c-Cbl becomes tyrosine phosphorylated by stimulation with GM-CSF or Epo and constitutively binds to the SH3 domain of Grb2/Ash in human hematopoietic cells.
Odai H; Sasaki K; Iwamatsu A; Hanazono Y; Tanaka T; Mitani K; Yazaki Y; Hirai H
J Biol Chem; 1995 May; 270(18):10800-5. PubMed ID: 7537740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
